September 4, 2025 – Pillar Biosciences, Inc., a leading provider of kitted next-generation sequencing (NGS) panels, and regulatory automation provider Platomics are collaborating to streamline compliance for next-generation sequencing (NGS) tests under the EU’s In Vitro Diagnostic Regulation (IVDR).
Now that IVDR has come into force, clinical laboratories must provide extensive regulatory documentation. Labs are often challenged to manage the time, expertise, and resources necessary to meet these rigorous regulatory demands.
Through this initiative, Pillar’s customers will benefit from the PlatoX® platform, which offers a structured system to complete their documentation based on direct product data, integrated guidance, automation, and an extensive regulatory knowledge base. The platform enables laboratories to easily navigate the regulatory requirements and help to maintain compliance over the lifecycle of their tests.
Data from Pillar’s panels is registered on the PlatoX® platform to provide laboratories with instant access to essential product data needed to complete the technical documentation for their tests. Rules-based automation ensures that the relevant product data is integrated where it is needed in audit-ready documentation created on the platform.”
“With the new IVDR coming into force, it is important for Pillar Biosciences to assist our customers with access to documentation and regulatory tools to help address these impending needs,“ said Jean Claude Gerard, Head of EMEA and WW Distribution for Pillar Biosciences. “We are pleased to collaborate with Platomics, who will provide access to these necessary and important tools through their intuitive PlatoX® platform.”
“At Platomics, we’re committed to empowering European clinical laboratories with seamless regulatory compliance and robust documentation tools,” said Rodrigo Berlie, CEO of Platomics. “I’m thrilled to announce our strategic collaboration with Pillar Biosciences, which brings together their NGS panel innovations and our intuitive PlatoX® platform — providing labs across the EU with streamlined, audit-ready documentation of NGS workflows. This cooperation represents a major step forward in speeding up workflow documentation while ensuring the highest standards of quality, transparency, and IVDR readiness.”
About Platomics
Platomics automates regulatory processes and connects in vitro diagnostic manufacturers and laboratories to accelerate compliance and bring innovation to patients faster. The PlatoX® platform saves time, resources and costs for all stakeholders involved in IVDR compliance by digitalizing regulatory work on the basis of intelligent data, not docs.
Contact Platomics
For more information visit platomics.com or connect with us on LinkedIn.
About Pillar Biosciences
Pillar Biosciences is a leading diagnostic manufacturer of targeted next-generation sequencing (NGS) panels. Our technology platforms help deliver accurate, efficient, and cost-effective genomic testing for laboratories across the globe, driving advances in cancer diagnostics and personalized treatment. Pillar Biosciences has operations in Natick, MA. For more information visit pillarbiosci.com and connect with them on LinkedIn.
Contact Pillar Biosciences
Brian Wright
Chief Marketing Officer
Pillar Biosciences
602-540-9522
wrightb@pillarbiosci.com